Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, announced that Snapdragon Chemistry has completed the second phase of its 51,000 square foot expansion in Waltham, Massachusetts. The expansion adds an additional 12,000 square feet to Snapdragon’s active pharmaceutical ingredient (API) development and manufacturing facility, including new process research and deve...